<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01334307</url>
  </required_header>
  <id_info>
    <org_study_id>CLN0008</org_study_id>
    <nct_id>NCT01334307</nct_id>
  </id_info>
  <brief_title>Randomized Comparison of the RePneu Lung Volume Reduction Coil (LVRC) to Standard of Care for the Treatment of Emphysema (RESET Study)</brief_title>
  <official_title>Randomized Controlled Trial Of RePneu (LVRC) Endobronchial Coils For The Treatment Of Severe Emphysema With Hyperinflation (RESET Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>PneumRx, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>PneumRx, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to demonstrate the safety and performance of the PneumRx, Inc.
      Lung Volume Reduction Coil (LVRC) in a population of patients with emphysema. The PneumRx,
      Inc. LVRC is used as a less invasive alternative to lung volume reduction surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>St. George's Respiratory Questionnaire (SGRQ)</measure>
    <time_frame>three month Follow-Up Visit</time_frame>
    <description>The primary efficacy endpoint will be the difference between treatment and control groups in the change in St. George's Respiratory Questionnaire (SGRQ) from Baseline (Pre-Treatment Visit) to the three month Follow-Up Visit.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">47</enrollment>
  <condition>Emphysema</condition>
  <arm_group>
    <arm_group_label>Lung Volume Reduction Coil (LVRC)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lung Volume Reduction Coil (LVRC)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Standard of Care</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lung Volume Reduction Coil (LVRC) (PneumRx)</intervention_name>
    <description>Lung Volume Reduction Coil (LVRC)</description>
    <arm_group_label>Lung Volume Reduction Coil (LVRC)</arm_group_label>
    <other_name>LVRD</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Standard of Care</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>LVRC Control treatment is Standard of Care</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient greater than or equal to 35 years of age

          -  High resolution CT scan indicates unilateral or bilateral emphysema

          -  High resolution CT scan indicates homogeneous or heterogeneous emphysema

          -  Patient has post-bronchodilator FEV1 less than or equal to 45% predicted

          -  Total Lung Capacity greater than 100% predicted

          -  Patient has marked dyspnea scoring greater than or equal to 2 on mMRC scale of 0-4

          -  Patient has stopped smoking for a minimum of 8 weeks prior to entering the study

          -  Patient (and legal guardian if applicable) read, understood and signed the Informed
             Consent form

        Exclusion Criteria:

          -  Patient has a change in FEV1 greater than 20% post-bronchodilator

          -  Patients DLCO less than 20% predicted

          -  Patient has a history of recurrent clinically significant respiratory infection

          -  Patient has uncontrolled pulmonary hypertension defined by right ventricular pressure
             greater than 50mm Hg and/or evidenced by echocardiogram

          -  Patient has an inability to walk greater than 140 meters (150 yards) in 6 minutes

          -  Patient has evidence of other disease that may compromise survival such as lung
             cancer, renal failure, etc

          -  Patient is pregnant or lactating

          -  Patient has an inability to tolerate bronchoscopy under heavy sedation or anesthesia

          -  Patient has clinically significant bronchiectasis

          -  Patient has giant bullae greater than 1/3 lung volume

          -  Patient has had previous LVR surgery, lung transplant or lobectomy

          -  Patient has been involved in other pulmonary drug studies with 30 days prior to this
             study

          -  Patient is taking greater than 20 mg prednisone (or similar steroid) daily

          -  Patient is on Plavix or has not been weaned off prior to procedure

          -  Patient has other disease that would interfere with completion of study, follow up
             assessments or that would adversely affect outcomes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pallav Shah, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chelsea and Westminster Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Glasgow</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chelsea and Westminster Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Manchester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2011</study_first_submitted>
  <study_first_submitted_qc>April 11, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 13, 2011</study_first_posted>
  <last_update_submitted>January 22, 2014</last_update_submitted>
  <last_update_submitted_qc>January 22, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Emphysema</keyword>
  <keyword>RePneu</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emphysema</mesh_term>
    <mesh_term>Pulmonary Emphysema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

